EUVIMEDEUVIMED entdecken
Crossref

Call for Research: Glucagon-like peptide-1 agonist Based Medications in Patients with Obesity and Chronic Pancreatitis May Be Associated with Decreased Major Adverse Cardiac Events

Shaina Ailawadi, Abbinaya Elangovan, Raj Shah

Pancreatology · 2026-11

DOI: 10.1016/j.pan.2026.11.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pancreatology, 2026-11. Verfasst von Shaina Ailawadi und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Michigan, Ann Arbor, MI, USA. Electronic address: shainaai@med.umich.edu. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • University of Michigan, Ann Arbor, MI, USA. Electronic address: shainaai@med.umich.edu.
  • Bon Secours St. Francis Medical Center, Greenville, SC, USA.
  • The Ohio State University, Columbus, OH, USA.

Zitieren

APA

Ailawadi, S., Elangovan, A., & Shah, R. (2026). Call for Research: Glucagon-like peptide-1 agonist Based Medications in Patients with Obesity and Chronic Pancreatitis May Be Associated with Decreased Major Adverse Cardiac Events. Pancreatology. https://doi.org/10.1016/j.pan.2026.11.006

Vancouver

Ailawadi S, Elangovan A, Shah R. Call for Research: Glucagon-like peptide-1 agonist Based Medications in Patients with Obesity and Chronic Pancreatitis May Be Associated with Decreased Major Adverse Cardiac Events. Pancreatology. 2026. doi:10.1016/j.pan.2026.11.006

BibTeX
@article{Ailawadi2026,
  author = {Ailawadi, Shaina and Elangovan, Abbinaya and Shah, Raj},
  title = {Call for Research: Glucagon-like peptide-1 agonist Based Medications in Patients with Obesity and Chronic Pancreatitis May Be Associated with Decreased Major Adverse Cardiac Events},
  journal = {Pancreatology},
  year = {2026},
  doi = {10.1016/j.pan.2026.11.006}
}
Kostenlos starten →